CN105535198A - Traditional Chinese medicine composition for treating poultry hydropericardium - Google Patents

Traditional Chinese medicine composition for treating poultry hydropericardium Download PDF

Info

Publication number
CN105535198A
CN105535198A CN201610065521.4A CN201610065521A CN105535198A CN 105535198 A CN105535198 A CN 105535198A CN 201610065521 A CN201610065521 A CN 201610065521A CN 105535198 A CN105535198 A CN 105535198A
Authority
CN
China
Prior art keywords
percent
chinese medicine
medicine composition
poultry
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610065521.4A
Other languages
Chinese (zh)
Other versions
CN105535198B (en
Inventor
刘易通
由佳
薛冬玲
王延鸿
李明举
唐少燕
高金霞
王淑娟
宋吉涛
田学磊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGDAO XNOBA BIOLOGICAL TECHNOLOGY Co Ltd
Original Assignee
QINGDAO XNOBA BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO XNOBA BIOLOGICAL TECHNOLOGY Co Ltd filed Critical QINGDAO XNOBA BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN201610065521.4A priority Critical patent/CN105535198B/en
Publication of CN105535198A publication Critical patent/CN105535198A/en
Application granted granted Critical
Publication of CN105535198B publication Critical patent/CN105535198B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Abstract

The invention discloses a traditional Chinese medicine composition for treating poultry hydropericardium. The traditional Chinese medicine composition is prepared from the following raw materials in percentage by weight: 10 percent to 40 percent of radix aconiti lateralis preparata, 10 percent to 30 percent of cortex cinnamomi, 5 percent to 20 percent of Chinese angelica, 5 percent to 20 percent of rhizoma Chuanxiong, 5 percent to 20 percent of tangerine peels, 5 percent to 15 percent of radix paeoniae alba, 5 percent to 15 percent of rhizoma atractylodis macrocephalae, 5 percent to 15 percent of poria cocos, 2 percent to 10 percent of ginseng leaves, 2 percent to 15 percent of prepared liquorice roots and 2 percent to 15 percent of fructus jujubae. The traditional Chinese medicine composition prepared by the invention accords with traditional Chinese medicine and veterinary medicine basic theories and can be used in a veterinary clinic. According to the traditional Chinese medicine composition as well as an application method and dosage of the traditional Chinese medicine composition, the traditional Chinese medicine composition has a definite treatment effect on the poultry hydropericardium, has a protection function on liver and has very good protection and rehabilitation functions on immune organs including kidneys, ovaries, thymus glands, bursa of fabricius and the like; after the medicine is digested and absorbed, the flavor of animal products (meat protein) can be improved; a defect of chemical drug residues is also avoided and a market requirements prospect is wide.

Description

A kind of Chinese medicine composition for the treatment of poultry pericardial effusion
Technical field
The invention belongs to technical field of veterinary, be specifically related to a kind of Chinese medicine composition for the treatment of poultry pericardial effusion.
Background technology
Recent years, occur that a kind of take pericardial effusion as the disease of key character more and more in poultry farming industry, relative to the poultry such as duck, goose, performance in broiler breeding field is particularly serious, sickness rate is not from 30% ~ 90% etc., mortality rate from 10% ~ 50% not etc., but mostly about 30%.At morbidity chicken house, removing is outside more stable key character with pericardial effusion, the general atrophy of immune organ such as pulmonary edema, hepatic necrosis, thymus and fabricius bursa that occur together in addition etc. one or several not etc., causing huge economic loss to poultry husbandry, is a hot issue of current veterinary clinic research.
From open report data and our practice, morbidity age in days focused mostly on 2 ~ 7 week age, and incubation period is generally no more than 4 days, and morbidity rapidly, usually presents sudden death in well-grown chicken group.Sometimes removing growth is slightly aobvious slowly be there is no other and significantly changes outward, only show as occur dead.Within initial 3 ~ 5 days, mortality rate is in rising trend, is peak mortality after 5 ~ 7 days, and the peak mortality phase can continue 5 ~ 8 days, then starts to reduce, the course of disease 10 ~ 14 days.The existing lassitude of sick chicken multilist, the fluffy and disorderly tarnish of feather, indivedual loss of appetite, feed intake do not increase or decline, and have individually partially white loose stool.
Dissect in visible pericardium and have more faint yellow jelly sample liquid body to be most important lesion characteristic.Other features have hepatic necrosis or color is mottled, have individually the slight edema of lungs, kidney or swelling or have the atrophy of immune organ such as urate deposition to a certain degree, thymus and fabricius bursa, development of ovary stagnation etc. or several not.Part sample can examine under a microscope hepatocyte intranuclear inclusion, also has people from pathological material of disease, be separated to parvovirus or adenovirus.
People have drawn different conclusions based on different research, but the effect being used for practice is often limited.Such as throw to different antibacterials, supplement different trace element, improve feeding and management condition, improve feedstuff quality, even make special yolk antibody etc. measure and still produce little effect, and some once effective measures often occur can not the phenomenon of repetition.In a word, for being which reason causes poultry to take pericardial effusion as the disease of key character actually, opinions vary, unable to decide which is right.Poultry pericardial effusion becomes disease at a loss what to do on veterinary clinic, become a difficult problem of puzzlement animal and veterinary industry, and this disease is causing increasing economic loss.
Therefore, be starved of in veterinary clinic practice find a kind of to poultry pericardial effusion effective, safe, cheap medicine or measure.
Summary of the invention
For problems of the prior art, for greater safety, more effectively alleviate with pericardial effusion be the disease of key character to the loss that causes of cultivation industry, the object of the present invention is to provide a kind of Chinese medicine composition for the treatment of poultry pericardial effusion.
The technical scheme that the present invention takes is:
Treat a Chinese medicine composition for poultry pericardial effusion, raw material each component is composed as follows according to percentage by weight:
Radix Aconiti Lateralis Preparata 10% ~ 40%, Cortex Cinnamomi 10% ~ 30%, Radix Angelicae Sinensis 5% ~ 20%, Rhizoma Chuanxiong 5% ~ 20%, Pericarpium Citri Reticulatae 5% ~ 20%, the Radix Paeoniae Alba 5% ~ 15%, the Rhizoma Atractylodis Macrocephalae 5% ~ 15%, Poria 5% ~ 15%, Folium Ginseng 2% ~ 10%, Radix Glycyrrhizae Preparata 2% ~ 15%, Fructus Jujubae 2% ~ 15%.
Further, described Chinese medicine composition is processed into powder, liquid, paste, granule, capsule or other pharmaceutically acceptable physical aspects.
Further, described Chinese medicine composition using method and consumption: said composition makes medicinal liquid through processing extraction, is watered 10kg ~ 1500kg freely drinks to poultry by 1 Hydrargyri Oxydum Rubrum liquid.
Further, described Chinese medicine composition is applied to preparation treatment stem cell injuries and improves the medicine of poultry meat local flavor.
Theoretical foundation involved in the present invention be exactly traditional in (beast) medical science.According in the guidance of (beast) medical science basic theories yin-yang and five elements and internal organs theory, for the pathogenesis causing clinical findings " pericardial effusion ", we think flaccidity of the heart-yang so that can not warm kidney water, can not give birth to hold up spleen soil so that spleen soil yang deficiency can not restrain kidney water, cause the not normal cause of edema with the liver involved catharsis again.Elaborate for:
On physiology, the five internal organs should life be held up, restrain, coordinate mutually, the relation of its center and kidney is more close, heart-yang should constantly decline as a means of kidney yang, heart-yang and the common warm kidney yin of kidney yang, to make the kidney being not cold, therefore on pathology, also can interact, and once flaccidity of the heart-yang, three adverse influences will be produced.
Flaccidity of the heart-yang, first just can not fulfil the warm function to kidney water well, so kidney water will tend to cold coagulation, produce the result that steam insults the heart, this is the main cause occurring gel-shaped hydrops in pericardium.
In addition, flaccidity of the heart-yang also produces two relevant impacts, an impact is that the raw spleen soil of holding up of heart-yang is not enough, cause spleen soil yang deficiency, the normal function that this causes " The spleen has the function to transport and transform nutrients; with stomach phase the exterior and the interior " is restricted, and shows as the function reduction of spleen transmitting and distributing the fluids, occurs that unnecessary water humidity hysteresis stay in the body, especially the cause exception of liquid in pericardium is accumulated; Another impact is " child-organ disease involving its motherorgan ", deficiency of heart-YANG thus irritability catharsis not normal, irritability catharsis not normal both with spleen soil yang deficiency joint effect appetite and digestive function, show as hepatic necrosis or color is mottled, feed intake declines, loose stool, fully can not dredge again sharp three Jiao and be elevated with logical water transfer liquid, show as water liquid dysbolismus, have unnecessary water humidity hysteresis to stay in body.
Above factor, causing with pericardial effusion is the disease of key character.Therefore, treatment should consider emphatically that warmly invigorating heart-YANG, invigorating spleen for diuresis, depressed liver-energy dispersing and QI regulating are advisable.
Beneficial outcomes of the present invention is:
Chinese medicine composition of the present invention selects Radix Aconiti Lateralis Preparata to be " monarch drug ", enters the heart, kidney, spleen channel, invigorating the heart-YANG, helps kidney yang with warm kidney yin kidney water, and cold is dispersed, and reduces the viscosity of gel-shaped pericardial effusion; Select Cortex Cinnamomi, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae to be altogether " ministerial drug ", to enter pericardium, kidney,spleen,liver warp, assist Radix Aconiti Lateralis Preparata with supporing yang cold expelling, realize promoting blood circulation to remove blood stasis, depressed liver-energy dispersing and QI regulating; Select the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae, Poria, Folium Ginseng to be altogether " adjuvant drug ", to enter the heart, liver, spleen, lung, kidney channel, the metabolism process of nourishing blood to suppress the hyperactive liver, invigorating the spleen and regulating the stomach, quickening superfluous water liquid, the delay of minimizing pericardial effusion; Select Radix Glycyrrhizae Preparata, Fructus Jujubae is " making medicine " altogether, enters the heart, spleen, stomach warp, and invigorating the heart-YANG strengthens Radix Aconiti Lateralis Preparata function and coordinating the actions of various ingredients in a prescription, plays the merit of " warmly invigorating heart-YANG, invigorating spleen for diuresis, depressed liver-energy dispersing and QI regulating " altogether.
Chinese medicine composition of the present invention has protective effect because adapted has the component such as the Radix Paeoniae Alba, Poria of nourishing blood to suppress the hyperactive liver function to the liver function of infected animal; the function of detoxification of liver can be strengthened, promote the raising of bile secretion and feed intake, strengthen renal tubules endotheliocyte elasticity and absorption function simultaneously, alleviate kidney swelling Cheng Du.
Chinese medicine composition of the present invention is because the components such as the adapted Rhizoma Atractylodis Macrocephalae, Folium Ginseng are by regulating the physiological function of the immune organ such as thymus and fabricius bursa, improve the cellular immunization of animal body and humoral immunization and strengthen basic resistance, in feeding process, greatly reduce incidence probability, extend the healthy growth time.
The component such as Chinese medicine composition Reasonable Radix Angelicae Sinensis of the present invention, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Cortex Cinnamomi, be rich in useful volatile liposoluble substance, the recovery of ovarian function can be promoted after digested absorption, the local flavor of dynamic property product (meat, egg, milk) can also be improved, thus the quality of consumption of animal food can be improved, the market demand has a extensive future.
Chinese medicine composition of the present invention contains kinds of traditional Chinese medicines, safety non-toxic, and separable chemical substance is very complicated, and corresponding efficacy effect is also just very many.Therefore, the multiformity of Chinese medicine composition component of the present invention is that the multiformity of function of the present invention provides material base, has extraordinary help for the raising health level of animal and the economic benefit of aquaculture.
Chinese medicine composition prepared by the present invention both met traditional in (beast) medical science basic theories, test with it on veterinary clinic again.By this Chinese medicine composition and using method thereof and consumption, for poultry pericardial effusion, there is clear and definite therapeutical effect, but also avoid the residual defect of chemicals, for the growth of promotion animal health, improve aquaculture economic benefit and ensure that animal food safety all has positive effect.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated.
Treat a Chinese medicine composition for poultry pericardial effusion, raw material each component is composed as follows according to percentage by weight: Radix Aconiti Lateralis Preparata 10% ~ 40%, Cortex Cinnamomi 10% ~ 30%, Radix Angelicae Sinensis 5% ~ 20%, Rhizoma Chuanxiong 5% ~ 20%, Pericarpium Citri Reticulatae 5% ~ 20%, the Radix Paeoniae Alba 5% ~ 15%, the Rhizoma Atractylodis Macrocephalae 5% ~ 15%, Poria 5% ~ 15%, Folium Ginseng 2% ~ 10%, Radix Glycyrrhizae Preparata 2% ~ 15%, Fructus Jujubae 2% ~ 15%.
Further, described Chinese medicine composition is processed into powder, liquid, paste, granule, capsule or pharmaceutically acceptable physical aspect.
Further, described Chinese medicine composition using method and consumption: said composition is made medicinal liquid through processing extraction, is watered 10kg ~ 1500kg by 1 Hydrargyri Oxydum Rubrum liquid and freely drinks to poultry.
Described compositions is through inspection, and its poisonous and harmful substance lead (pb), arsenic (As) content all do not exceed " People's Republic of China's veterinary drug allusion quotation two " specified standard.
Embodiment 1
Certain small-sized chicken farm, the fast large-scale meat chicken of 21 age in days, totally four canopies, every canopy is all more than 7900, and jumpbogroup overall condition is substantially all normal.Wherein only have No. 3 canopies and No. 4 canopies to occur the change that dead quantity is higher in continuous two days, reach 68,73.Through examining and inquiring raiser, feed intake is a Bag Material fewer than standard feed intake, and feces, drinking-water, the chicken group mental status, ventilation, temperature are normal, show no obvious abnormalities generally.Dead chicken is judged as through anatomical diagnosis and dies from " excessive pericardial effusion ", main lesion characteristic is: what have more faint yellow jelly sample liquid body in pericardium accounts for 7/13, what have a small amount of faint yellow jelly sample liquid body in pericardium accounts for 5/13, and in pericardium, no abnormality seen accounts for 1/13; Simultaneously with liver irregular colour one and have a downright bad point account for 6/13, liver irregular colour once there is no a downright bad point account for 6/13, liver outward appearance accounts for 1/13 normally; What there was the slight swelling in a place or many places at other organs such as lungs and kidney and position accounts for 5/13, and what have no swelling accounts for 8/13.
So with center-aisle in hen house for boundary is divided into A, B two groups chicken group, as a control group, B group is as test group for A group.
Matched group adopts the pessimistic scheme of " florfenicol powder " drinking-water+Chinese medicine " WULING SAN " spice according to general measures.Commercially available 10% florfenicol powder is according to the dosage dispensing drinking-water of every 1kg body weight 20mg; WULING SAN admixes the ratio spice administration of 500kg complete feed according to 1kg, continuously treatment 4 days.
Test group uses Chinese medicine composition of the present invention as treatment medicine.According to the ratio of Radix Aconiti Lateralis Preparata 25kg, Cortex Cinnamomi 10kg, Radix Angelicae Sinensis 5kg, Rhizoma Chuanxiong 10kg, Pericarpium Citri Reticulatae 10kg, Radix Paeoniae Alba 5kg, Rhizoma Atractylodis Macrocephalae 10kg, Poria 10kg, Folium Ginseng 5kg, Radix Glycyrrhizae Preparata 5kg, Fructus Jujubae 5kg, add 8 times of soak by water twice, merge concentrated after twice medicinal liquid, leave standstill, filter, to get supernatant subpackage for subsequent use.Be watered 800kg by 1 Hydrargyri Oxydum Rubrum liquid and freely drink 5 days to the morbidity chicken group of pericardial effusion.
Embodiment 2
Treat a Chinese medicine composition for poultry pericardial effusion, raw material each component is composed as follows according to percentage by weight:
Radix Aconiti Lateralis Preparata 10kg, Cortex Cinnamomi 30kg, Radix Angelicae Sinensis 5kg, Rhizoma Chuanxiong 20kg, Pericarpium Citri Reticulatae 5kg, Radix Paeoniae Alba 15kg, Rhizoma Atractylodis Macrocephalae 6kg, Poria 5kg, Folium Ginseng 2kg, Radix Glycyrrhizae Preparata 2kg, Fructus Jujubae 2kg.Add 8 times of soak by water twice, merge concentrated after twice medicinal liquid, leave standstill, filter, to get supernatant subpackage for subsequent use.Be watered 1200kg by 1 Hydrargyri Oxydum Rubrum liquid and freely drink 5 days to the morbidity chicken group of pericardial effusion.
Embodiment 3
Treat a Chinese medicine composition for poultry pericardial effusion, raw material each component is composed as follows according to percentage by weight:
Radix Aconiti Lateralis Preparata 40kg, Cortex Cinnamomi 9kg, Radix Angelicae Sinensis 20kg, Rhizoma Chuanxiong 5kg, Pericarpium Citri Reticulatae 5kg, Radix Paeoniae Alba 5kg, Rhizoma Atractylodis Macrocephalae 5kg, Poria 5kg, Folium Ginseng 2kg, Radix Glycyrrhizae Preparata 2kg, Fructus Jujubae 2kg.Add 8 times of soak by water twice, merge concentrated after twice medicinal liquid, leave standstill, filter, to get supernatant subpackage for subsequent use.Be watered 1000kg by 1 Hydrargyri Oxydum Rubrum liquid and freely drink 5 days to the morbidity chicken group of pericardial effusion.
Embodiment 4
Treat a Chinese medicine composition for poultry pericardial effusion, raw material each component is composed as follows according to percentage by weight:
Radix Aconiti Lateralis Preparata 10kg, Cortex Cinnamomi 10kg, Radix Angelicae Sinensis 5kg, Rhizoma Chuanxiong 5kg, Pericarpium Citri Reticulatae 5kg, Radix Paeoniae Alba 5kg, Rhizoma Atractylodis Macrocephalae 15kg, Poria 15kg, Folium Ginseng 10kg, Radix Glycyrrhizae Preparata 10kg, Fructus Jujubae 10kg.Add 8 times of soak by water twice, merge concentrated after twice medicinal liquid, leave standstill, filter, to get supernatant subpackage for subsequent use.Be watered 900kg by 1 Hydrargyri Oxydum Rubrum liquid and freely drink 5 days to the morbidity chicken group of pericardial effusion.
Embodiment 5
Treat a Chinese medicine composition for poultry pericardial effusion, raw material each component is composed as follows according to percentage by weight:
Radix Aconiti Lateralis Preparata 20kg, Cortex Cinnamomi 20kg, Radix Angelicae Sinensis 10kg, Rhizoma Chuanxiong 10kg, Pericarpium Citri Reticulatae 8kg, Radix Paeoniae Alba 8kg, Rhizoma Atractylodis Macrocephalae 7kg, Poria 7kg, Folium Ginseng 3kg, Radix Glycyrrhizae Preparata 3kg, Fructus Jujubae 4kg.Add 8 times of soak by water twice, merge concentrated after twice medicinal liquid, leave standstill, filter, to get supernatant subpackage for subsequent use.Be watered 900kg by 1 Hydrargyri Oxydum Rubrum liquid and freely drink 5 days to the morbidity chicken group of pericardial effusion.
The jumpbogroup mental status of matched group and test group, feed intake, dead quantity and pericardial effusion situation thereof is added up respectively at the 5th day.Statistical result represents with average, as shown in the table.
Analysis of conclusion:
1. in jumpbogroup mental status, test group is obviously well a lot of than matched group, illustrates that Chinese medicine composition of the present invention is compared with common compatibility of drugs scheme, and in recovery chicken group general health, effect is obvious.
2. in average feed intake, test group on average exceeds matched group 16.5%, and substantially close to normal feed intake, illustrates that Chinese medicine composition of the present invention is compared with common compatibility of drugs scheme, has the effect recovering feed intake faster.
3. at dead quantitative aspects, test group on average low go out matched group 75.6%, the therapeutic scheme Endodontic failure of matched group is described, also illustrates that Chinese medicine composition of the present invention can the death that causes because of pericardial effusion of fast treating.
4. cuing open in inspection observation live chickens pericardial effusion situation, matched group 5/5 pericardium all has more faint yellow gel-shaped hydrops, and embodiment 2,3 test group only has 1/5 visible micro-pericardial effusion but almost close to normal amount, illustrate that Chinese medicine composition of the present invention has faster and better curative effect in treatment chicken pericardial effusion.
In summary, the oral liquid that the present invention makes through extraction process has clear and definite therapeutical effect for poultry pericardial effusion, but also avoids the residual defect of chemicals.
The above, be only the specific embodiment of the present invention, is not limited thereto, and is anyly familiar with those skilled in the art in the technical scope that this patent discloses, the change that can expect easily or replacement, all should be encompassed within protection scope of the present invention.

Claims (4)

1. treat the Chinese medicine composition of poultry pericardial effusion for one kind, it is characterized in that, raw material each component is composed as follows according to percentage by weight: Radix Aconiti Lateralis Preparata 10% ~ 40%, Cortex Cinnamomi 10% ~ 30%, Radix Angelicae Sinensis 5% ~ 20%, Rhizoma Chuanxiong 5% ~ 20%, Pericarpium Citri Reticulatae 5% ~ 20%, the Radix Paeoniae Alba 5% ~ 15%, the Rhizoma Atractylodis Macrocephalae 5% ~ 15%, Poria 5% ~ 15%, Folium Ginseng 2% ~ 10%, Radix Glycyrrhizae Preparata 2% ~ 15%, Fructus Jujubae 2% ~ 15%.
2. the Chinese medicine composition for the treatment of poultry pericardial effusion according to claim 1, it is characterized in that, described Chinese medicine composition is processed into powder, liquid, paste, granule, capsule or other pharmaceutically acceptable physical aspects.
3. the Chinese medicine composition for the treatment of poultry pericardial effusion according to claim 1 and 2, it is characterized in that, described Chinese medicine composition using method and consumption: said composition makes medicinal liquid through processing extraction, is watered 10kg ~ 1500kg freely drinks to poultry by 1 Hydrargyri Oxydum Rubrum liquid.
4. the Chinese medicine composition for the treatment of poultry pericardial effusion according to claim 1 and 2, is characterized in that, described Chinese medicine composition is applied to preparation treatment stem cell injuries and improves the medicine of poultry meat local flavor.
CN201610065521.4A 2016-01-29 2016-01-29 Traditional Chinese medicine composition for treating poultry hydropericardium Active CN105535198B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610065521.4A CN105535198B (en) 2016-01-29 2016-01-29 Traditional Chinese medicine composition for treating poultry hydropericardium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610065521.4A CN105535198B (en) 2016-01-29 2016-01-29 Traditional Chinese medicine composition for treating poultry hydropericardium

Publications (2)

Publication Number Publication Date
CN105535198A true CN105535198A (en) 2016-05-04
CN105535198B CN105535198B (en) 2020-03-31

Family

ID=55815114

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610065521.4A Active CN105535198B (en) 2016-01-29 2016-01-29 Traditional Chinese medicine composition for treating poultry hydropericardium

Country Status (1)

Country Link
CN (1) CN105535198B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105878716A (en) * 2016-05-30 2016-08-24 山东省农业科学院家禽研究所 Chinese herbal medicine compound preparation for preventing and treating chicken hydropericardium syndrome
CN106729707A (en) * 2017-01-19 2017-05-31 天津市中升挑战生物科技有限公司 A kind of composite yolk antibody for prophylactic treatment chicken hydropericardium hepatitis syndrome and preparation method thereof
CN108478639A (en) * 2018-05-28 2018-09-04 安徽科技学院 Chinese medicine composition and its preparation method and application for treating/preventing poultry Ankara disease
CN113117011A (en) * 2021-06-04 2021-07-16 济南广盛源生物科技有限公司 Traditional Chinese medicine composition for preventing and treating poultry hydropericardium syndrome

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349819A (en) * 2001-10-29 2002-05-22 程绍恩 Myocarditis treating Chinese medicine prepn
CN1380098A (en) * 2002-05-20 2002-11-20 张勇飞 Anti-infection compound preparation and its preparation method
CN101380439A (en) * 2007-09-07 2009-03-11 中国科学院沈阳应用生态研究所 Chinese herbal medicine feed additive for preventing and treating ascites syndrome in broilers and preparation method thereof
CN102327378A (en) * 2011-09-29 2012-01-25 广东紫金正天药业有限公司 Medicinal composition for preventing and treating porcine myocarditis
CN103110694A (en) * 2011-11-17 2013-05-22 广东紫金正天药业有限公司 Composition for widely treating viral diseases and application thereof
CN104258282A (en) * 2014-09-25 2015-01-07 青岛众泰禽业专业合作社 Method for preparing medicines used for broiler breeding
CN105250440A (en) * 2015-11-04 2016-01-20 刘宇清 Pain-alleviating traditional Chinese medicine composition and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349819A (en) * 2001-10-29 2002-05-22 程绍恩 Myocarditis treating Chinese medicine prepn
CN1380098A (en) * 2002-05-20 2002-11-20 张勇飞 Anti-infection compound preparation and its preparation method
CN101380439A (en) * 2007-09-07 2009-03-11 中国科学院沈阳应用生态研究所 Chinese herbal medicine feed additive for preventing and treating ascites syndrome in broilers and preparation method thereof
CN102327378A (en) * 2011-09-29 2012-01-25 广东紫金正天药业有限公司 Medicinal composition for preventing and treating porcine myocarditis
CN103110694A (en) * 2011-11-17 2013-05-22 广东紫金正天药业有限公司 Composition for widely treating viral diseases and application thereof
CN104258282A (en) * 2014-09-25 2015-01-07 青岛众泰禽业专业合作社 Method for preparing medicines used for broiler breeding
CN105250440A (en) * 2015-11-04 2016-01-20 刘宇清 Pain-alleviating traditional Chinese medicine composition and application thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
刘玉山等: "鸡心包积液综合征的诊治", 《家禽科学》 *
孙强东: "疑似鸡心包积液综合征的诊治", 《今日畜牧兽医》 *
孙桂芹: "鸡心包积液综合征的防治", 《河北科技报》 *
杨晓晖等: "《当代心脑肾肝胆病医方集成》", 30 September 2003, 中国医药科技出版社 *
陈秋鹏: "中兽医辨证治疗鸡"安卡拉病"", 《中兽医学杂志》 *
陈鹏举等: "自拟中药茯白散对鸡心包积液-肝炎综合症的治疗效果分析", 《中兽医学杂志》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105878716A (en) * 2016-05-30 2016-08-24 山东省农业科学院家禽研究所 Chinese herbal medicine compound preparation for preventing and treating chicken hydropericardium syndrome
CN105878716B (en) * 2016-05-30 2019-09-13 山东省农业科学院家禽研究所 A kind of Chinese herbal compound preparation for preventing and treating chicken hydropericardium syndrome
CN106729707A (en) * 2017-01-19 2017-05-31 天津市中升挑战生物科技有限公司 A kind of composite yolk antibody for prophylactic treatment chicken hydropericardium hepatitis syndrome and preparation method thereof
CN106729707B (en) * 2017-01-19 2021-08-24 天津市中升挑战生物科技有限公司 Composite yolk antibody for preventing and treating chicken pericardial effusion-hepatitis syndrome and preparation method thereof
CN108478639A (en) * 2018-05-28 2018-09-04 安徽科技学院 Chinese medicine composition and its preparation method and application for treating/preventing poultry Ankara disease
CN108478639B (en) * 2018-05-28 2020-11-10 安徽科技学院 Traditional Chinese medicine composition for treating/preventing poultry Ankara disease and preparation method and application thereof
CN113117011A (en) * 2021-06-04 2021-07-16 济南广盛源生物科技有限公司 Traditional Chinese medicine composition for preventing and treating poultry hydropericardium syndrome

Also Published As

Publication number Publication date
CN105535198B (en) 2020-03-31

Similar Documents

Publication Publication Date Title
CN103392936B (en) Compound feed for broilers at age between 1 day and 42 days and preparation method thereof
CN102845638B (en) Duck feed capable of preventing and treating avian influenza and Chinese herbal additive used therein
CN101698024B (en) Traditional Chinese medicine for treating respiratory diseases and promoting growth for swine and preparation method thereof
CN104824478A (en) Breeding method of high-quality broiler chicken
CN105639169A (en) Feed capable of enhancing immunity of chicken
CN104800819B (en) A kind of Chinese medicine preparation for treating checken pest
CN105535198A (en) Traditional Chinese medicine composition for treating poultry hydropericardium
CN101066313A (en) Chinese medicine prepn for antagonizing bacteria and viruses of pig and improving pork quality and its prepn process
CN105166544A (en) Pig mixed feed and preparation method thereof
CN102641366A (en) Traditional Chinese medicine composition for preventing and treating proventriculitis and gizzard erosion of poultry
CN101695529A (en) Compound Chinese herbal medicinal preparation for preventing and controlling bacterial enteritis, black gill and red skin disease of freshwater fish
CN100453107C (en) Natural botanical extraction liquid for preventing and treating livestock and birds respiratory disease and preparation process thereof
CN103609893A (en) Cattle feed for promoting digestion
CN104095142B (en) Traditional Chinese medicine additive for crocodylus siamensis feed
CN102078372A (en) Chinese herbal medicine composition for enhancing disease resistance of broiler chickens
CN101972433A (en) Medicine composition for increasing eggs of laying hen and preparation method thereof
CN104225416B (en) Chinese veterinary drug for accelerating after-disease feed intake recovery of poultry and preparation method of Chinese veterinary drug
CN102319318B (en) Chinese medicinal superfine powder preparation for preventing and treating heat toxin and blood dysentery of chicken and preparation method thereof
CN104258165A (en) Pharmaceutical preparation for preventing loach from hemorrhagic disease
CN104147568A (en) Traditional Chinese medicinal oral liquid for treating poultry infectious proventriculitis, and preparation method thereof
CN103610975A (en) Preparation method of cattle medicine for promoting digestion
CN107647177A (en) A kind of feed additive for egg-laying ducks and preparation method thereof
CN105727225A (en) Curcuma oil feed additive for preventing and treating livestock and poultry digestive tract diseases
CN102824493B (en) Bupleurum tenue oral liquid for veterinary use and preparation method thereof
CN107510771B (en) Traditional Chinese medicine composition for treating duck aeromonas hydrophila disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant